Author

Kaltin Ferguson

The University of QueenslandORCID 0009-0000-2148-4380Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1

Frequent Co-Authors

Gwo‐Yaw HoiD· 2 shared A. Ferrier· 1 shared A. Glasgow· 1 shared A. Mellon· 1 shared Adam C. Martyn· 1 shared Adèle C. GreeniD· 1 shared Alan J. RobertsoniD· 1 shared Alexander DobroviciD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gwo‐Yaw HoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyBritish Journal of CancerPeer-reviewedApr 7, 2026

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer

Zhen Zeng, Anastasia Gandini, Rituparna Bhatt…·Brian G. Gabrielli

This study evaluates CHK1i+LDHU therapy in HGSOC, showing it kills cancer cells and reprograms the tumor microenvironment to enhance anti-tumor immune responses.

1 citation

mouseexperimental assay

𝕏 PostBluesky

Genetic & Genomic MedicineMolecular CancerPeer-reviewedAug 5, 2024

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

Ksenija Nesic, John J. Krais, Yifan Wang…·Lyndal S. Edwards

This study identifies secondary splice-site mutations in BRCA1 that drive exon skipping and PARP inhibitor resistance in ovarian and breast cancer.

36 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMar 28, 2018

Profiling copy number alterations in cell-free tumour DNA using a single-reference

Alan J. Robertson, Qinying Xu, Sarah Song…·Lachlan Coin

This paper introduces qCNV and sCNA-seq tools to profile somatic copy number alterations in cell-free DNA without a reference panel, showing effectiveness in detecting clinically relevant mutations from plasma samples.

DOI 10.1101/290171

humanwhole-genome sequencing

𝕏 PostBluesky